Navigation Links
HUYA Bioscience Announces Strategic Collaboration With the Shenyang Pharmaceutical University
Date:6/8/2009

SAN DIEGO, June 8 /PRNewswire/ -- HUYA Bioscience International, a leader in enabling and accelerating the global co-development of novel biopharmaceutical product opportunities originating in China, today announced a strategic drug co-development partnership with the Shenyang Pharmaceutical University. The agreement covers a wide range of therapeutic areas and represents one of the first official collaborations of its kind between a U.S. biotech company and a Chinese university.

HUYA is one of the first companies to have recognized China's potential to help meet the global need for new pre-clinical and clinical stage compounds. The agreement with Shenyang Pharmaceutical University provides HUYA with rights of first review and negotiation relating to certain novel therapeutic compounds owned or controlled by the University. In return, Shenyang Pharmaceutical University gains access to HUYA's global network of pharmaceutical partners and its expertise in pre-clinical and clinical development.

"Shenyang Pharmaceutical University is a leading pharmaceutical institution with a tradition of innovation," said Mireille Gingras, PhD, President and CEO of HUYA. "We are enthusiastic about collaborating with this University to develop new products for global markets."

Enhancing its collaboration with Shenyang Pharmaceutical University, HUYA has key partnerships with leading global pharmaceutical companies such as Solvay Pharmaceuticals, Abbott, and Schering-Plough. By establishing an extensive global network and world-class drug development capabilities HUYA has become the partner-of-choice for Chinese institutions, universities and biopharma companies looking to maximize the value of their pre-clinical and clinical stage drugs for global markets. HUYA has acquired the development and commercialization rights to two novel development stage drug candidates sourced from China and is developing these candidates in the U.S.
'/>"/>

SOURCE HUYA Bioscience International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... AudioNotch is the ... treatment. AudioNotch is pleased to announce a partnership ... in both British Columbia and Alberta, Destination Hearing ... services. AudioNotch's tinnitus treatment program is now available ... Destination Hearing clinic, patients have the detection of ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Envera ... as Fermentation Manager. Mr. McErlean has an extensive ... of leadership positions throughout his career. , ... are very pleased to have Mike join our team”. ... installed large scale fermentation and downstream processing ...
(Date:5/21/2013)... , May 22, 2013 ... drug-only formulation of glycopyrronium bromide designed using Prosonix, particle ... company developing a portfolio of inhaled Respiratory Medicines ... study with PSX1002 that will assess its effect on ... doses in patients with moderate to severe chronic obstructive ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building optical ... organizations will continue their work to increase awareness about ... daily life with the aid of SPIE Education ... countries, are the first of two groups of recipients ... international society for optics and photonics , in 2013. ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Envera Appoints Michael McErlean Fermentation Manager 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3
... film or drop of liquid and the shape of the ... mathematical formula published this week in Physical Review Letters. ... important for a number of areas, including the chemical industry ... to explain how the relationship between the liquid and the ...
... its presence in Europe ... its methodological expertise., BOSTON, April 7, 2008 The ... a Director based in the United,Kingdom. Penny will work closely ... the company,s European and global,business. Penny specializes in the provision ...
... BioSpace, the world,s,leading online bioscience job board and ... Label Career Fair for Regeneron Pharmaceuticals on,Thursday, April ... the Hanover Marriott,in Whippany, New Jersey from 1 ... ), Regeneron is looking to fill ...
Cached Biology Technology:Physicists saved from drowning in complexities of wetting theory 2Observant LLC Appoints Two New Directors to the Senior Management Team 2BioSpace to Host Regeneron Pharmaceuticals Career Fair in Whippany, New Jersey 2
(Date:5/22/2013)... is responsible for legionellosis, an infectious disease that can ... pathogen has developed a complex method enabling it to ... avoiding these acting against the infectious bacteria. , Research ... in which teams from the National Institute of Health ... in Barcelona (BSC) have also participated, has described for ...
(Date:5/22/2013)... additives known as phthalates (pronounced THAL-ates) are odorless, ... in flooring, plastic cups, beach balls, plastic wrap, ... Control and Preventionthe bodies of most Americans. Once ... scrutiny. A growing collection of evidence suggests dietary ... and mix with food) may cause significant metabolic ...
(Date:5/21/2013)... shows that the nation,s land and water resources could ... up to 25 billion gallons of algae-based fuel a ... yearly needs. , The findings come from an in-depth ... to grow significant amounts of algae in large, specially ... May 7 issue of Environmental Science and Technology ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... two or more induced abortions have a reduced risk of ... what degree physical activity during pregnancy protects against pre-eclampsia, compared ... from the Norwegian Institute of Public Health (NIPH) that use ... The new results from MoBa were presented on ...
... that plants growing under unfavourable conditions are generally smaller than ... in the US, abiotic stress reduces the yield of agricultural ... the effect of stress in this case, repeated wounding ... which every aspect of their stature, including height, girth, and ...
... A team of researchers led by North Carolina State University ... devices and a host of other revolutionary medical implants. The ... material can be used to create new devices that can ... sensors for diabetics and artificial hemo-dialysis membranes that can scrub ...
Cached Biology News:Previous abortions and exercise: Do they affect pregnancy? 2Previous abortions and exercise: Do they affect pregnancy? 3The bonsai effect: Wounded plants make jasmonates, inhibiting cell division, stunting growth 2NC State finds new nanomaterial could be breakthrough for implantable medical devices 2
Mouse monoclonal antibody raised against a partial recombinant CENTB2. NCBI Entrez Gene ID = CENTB2...
... tubing prep station, 100-120 V, is used to ... gold particles to create the source of the ... with the Helios gene gun. The station includes ... prep unit, 12 foot Nalgene nitrogen regulator hose, ...
Mouse polyclonal antibody to NR2F2 - nuclear receptor subfamily 2, group F, member 2...
The Discovery Series PDQuest 2-D analysis software is used for imaging, analyzing, and databasing two-dimensional electrophoretic gels. The 10-user network license entitles ten users to access data f...
Biology Products: